Efficacy News and Research

RSS

USF researchers test a protein that shows potential as novel therapeutic for ALS patients

Researchers at the USF Health Morsani College of Medicine, located at the University of South Florida, successfully tested a protein that has the potential to aid in the development of a protein-based therapy for patients with ALS, a progressive nervous system disease, also known as Lou Gehrig's disease, that affects nerve cells in the brain and spinal cord.

7 Oct 2022

Simple new symptom-based screening tool detects asthma risk in young children

A team of researchers working with the CHILD Cohort Study (CHILD) has developed a simple new symptom-based screening tool that detects asthma risk in children as young as two years of age.

7 Oct 2022

Clinical trial to examine new tools to improve psychological treatment for young people with depression

Some studies have shown alarming numbers of young people suffering from symptoms of depression.

6 Oct 2022

Clinical trials of novel COVID-19 vaccine developed in Brazil to begin soon

Testing on humans of a novel COVID-19 vaccine developed in Brazil will begin this year. It performed well in animal trials, as reported in an article published in August in Nature Communications.

6 Oct 2022

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

Researchers evaluated the efficacy of dNS1-RBD, a novel intranasal COVID-19 vaccine.

6 Oct 2022

$The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series$

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

Researchers evaluated the vaccine effectiveness of half-doses of AZD1222 or BNT162b2 COVID-19 vaccines as a booster dose following primary series vaccination with CoronaVac.

6 Oct 2022

Environmental surveillance of SARS-CoV-2 could predict COVID-19 cases

A new study reported that coronavirus disease 2019 (COVID-19) cases could be predicted by environmental surveillance.

6 Oct 2022

The neuroprotective potential of Cannabis sativa L. against Alzheimer's disease

A recent study assesses the neuroprotective potential of the active constituents of cannabis in treating dementia and Alzheimer's disease.

6 Oct 2022

Discovery opens up new approaches to personalized treatment for small cell lung cancer

Small cell lung cancer is a particularly aggressive tumor, which has so far been treated with standardized measures.

6 Oct 2022

Northwestern Medicine scientists discover new gene target for aggressive lung cancer

Northwestern Medicine scientists have identified and described a new gene that is responsible for activating an aggressive subtype of small-cell lung cancer, the P subtype, for which there is no current effective treatment.

5 Oct 2022

NYU researchers collaborate with FDA to design first-ever stroke rehabilitation regulatory science tool

Stroke is the leading cause of age-related motor disabilities and is becoming more prevalent in younger populations as well.

5 Oct 2022

Smartphone App could help advance the early detection of Parkinson's disease and severe COVID-19

A new screening test App could help advance the early detection of Parkinson's disease and severe COVID-19, improving the management of these illnesses.

5 Oct 2022

Transient cell-in-cell formation by tumor cells found to build resistance to immunotherapy

Researchers demonstrated that tumor cells evade immunotherapy by generating unique transient cell-in-cell structures, resistant to chemotherapy and destruction by T cells.

5 Oct 2022

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Researchers engineered biparatopic nanobodies against SARS-CoV-2.

5 Oct 2022

Novel protein vaccine NVX-CoV2373 triggered functional T cell responses to SARS-CoV-2

Researchers determined the T cell response to the NVX-CoV2373, an adjuvanted recombinant full-length SARS-CoV-2 spike (S) trimer protein vaccine.

5 Oct 2022

Study finds the majority of post-vaccination monkeypox infections occur within 2 weeks of receiving the first dose of MVA-BN

Researchers described the human monkeypox virus infection after vaccination with the modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine.

5 Oct 2022

Efficacy News and Research

USF researchers test a protein that shows potential as novel therapeutic for ALS patients

Simple new symptom-based screening tool detects asthma risk in young children

Clinical trial to examine new tools to improve psychological treatment for young people with depression

Clinical trials of novel COVID-19 vaccine developed in Brazil to begin soon

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

Environmental surveillance of SARS-CoV-2 could predict COVID-19 cases

The neuroprotective potential of Cannabis sativa L. against Alzheimer's disease

Discovery opens up new approaches to personalized treatment for small cell lung cancer

Northwestern Medicine scientists discover new gene target for aggressive lung cancer

NYU researchers collaborate with FDA to design first-ever stroke rehabilitation regulatory science tool

Smartphone App could help advance the early detection of Parkinson's disease and severe COVID-19

Transient cell-in-cell formation by tumor cells found to build resistance to immunotherapy

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Novel protein vaccine NVX-CoV2373 triggered functional T cell responses to SARS-CoV-2

Study finds the majority of post-vaccination monkeypox infections occur within 2 weeks of receiving the first dose of MVA-BN

What is the COVID-19 mRNA-1273 vaccine effectiveness against SARS-CoV-2 Omicron sub-variants?

Small antiviral molecules termed assembly modulators show therapeutic efficacy against cancer

What are the challenges of COVID-19 vaccination and herd immunity?

Nursing home study shows 4th COVID mRNA dose provides extra protection against severe Omicron outcomes

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News